1. Home
  2. MREO vs CMTG Comparison

MREO vs CMTG Comparison

Compare MREO & CMTG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MREO
  • CMTG
  • Stock Information
  • Founded
  • MREO 2015
  • CMTG 2015
  • Country
  • MREO United Kingdom
  • CMTG United States
  • Employees
  • MREO N/A
  • CMTG N/A
  • Industry
  • MREO Biotechnology: Pharmaceutical Preparations
  • CMTG Real Estate Investment Trusts
  • Sector
  • MREO Health Care
  • CMTG Real Estate
  • Exchange
  • MREO Nasdaq
  • CMTG Nasdaq
  • Market Cap
  • MREO 438.8M
  • CMTG 359.3M
  • IPO Year
  • MREO N/A
  • CMTG 2021
  • Fundamental
  • Price
  • MREO $1.76
  • CMTG $3.18
  • Analyst Decision
  • MREO Strong Buy
  • CMTG Hold
  • Analyst Count
  • MREO 5
  • CMTG 5
  • Target Price
  • MREO $7.20
  • CMTG $4.06
  • AVG Volume (30 Days)
  • MREO 4.4M
  • CMTG 682.7K
  • Earning Date
  • MREO 08-12-2025
  • CMTG 08-06-2025
  • Dividend Yield
  • MREO N/A
  • CMTG 3.15%
  • EPS Growth
  • MREO N/A
  • CMTG N/A
  • EPS
  • MREO N/A
  • CMTG N/A
  • Revenue
  • MREO N/A
  • CMTG $22,189,000.00
  • Revenue This Year
  • MREO N/A
  • CMTG $2,076.54
  • Revenue Next Year
  • MREO $51.92
  • CMTG N/A
  • P/E Ratio
  • MREO N/A
  • CMTG N/A
  • Revenue Growth
  • MREO N/A
  • CMTG N/A
  • 52 Week Low
  • MREO $1.57
  • CMTG $2.13
  • 52 Week High
  • MREO $5.02
  • CMTG $9.81
  • Technical
  • Relative Strength Index (RSI)
  • MREO 35.35
  • CMTG 54.49
  • Support Level
  • MREO $1.65
  • CMTG $3.03
  • Resistance Level
  • MREO $1.89
  • CMTG $3.39
  • Average True Range (ATR)
  • MREO 0.15
  • CMTG 0.15
  • MACD
  • MREO -0.03
  • CMTG -0.00
  • Stochastic Oscillator
  • MREO 12.84
  • CMTG 47.47

About MREO Mereo BioPharma Group plc

Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of therapeutics for rare diseases. The company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat primarily for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).

About CMTG Claros Mortgage Trust Inc.

Claros Mortgage Trust Inc is a real estate investment trust. The company is focused mainly on creating a diversified portfolio of income-producing loans collateralized by institutional quality commercial real estate.

Share on Social Networks: